Neurocrine Biosciences, Inc. (0K6R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 03:59PM BST. Market open.
| Previous close | 141.25 |
| Open | 141.98 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 141.00 - 142.57 |
| 52-week range | 89.66 - 143.27 |
| Volume | |
| Avg. volume | 1,189 |
| Market cap | 140.149M |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | 1.95 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Neurocrine Biosciences is making good on its promise to diversify from Ingrezza. Meanwhile, the biotech stock is angling for a record.
- Investor's Business Daily
Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.
- Simply Wall St.
Neurocrine Biosciences First Quarter 2024 Earnings: EPS Misses Expectations
Neurocrine Biosciences ( NASDAQ:NBIX ) First Quarter 2024 Results Key Financial Results Revenue: US$515.3m (up 23% from...
© 2024 Yahoo. All rights reserved.